Swirl Season To Debut Two Albums In All Nashville
Swirl Season To Debut Two Albums In All Stores This February
According to sources, Swirl Season’s “Wolfpack: No Taming (Vol. 001)” mixtape will debut on all platforms on February 3, 2021.
A second project will debut on February, 14, 2021. That project will be a re-release album titled “Romeo’s Dead” which will contain modifications of the original 2018 release.
Other News Nashville
NASHVILLE WEEKLY WEATHER UPDATE
As per the 7 day prediction from the robot-powered weather channel Saildrenone, Nashville is expected to cause moderate showers in the next few days. The rain best opportunity is expected from Thurs through Fridays. Thursday will see the maximum precipitation, with 1.00 inch of forecast precipitation.
Even now the instant weather has light winds in town. On Thurs, winds are expected to rise up to Nineteen miles whereas currently will be cooler with a maximum velocity of just Thirteen miles.
Temps on Sunday will hit their lowest point of the week, dropping to 64 degree and remain cool across Monday.
Nashville Governor John Cooper stated Monday that while partnering with just the biggest Tennessee towns to restart the market he plans to expand his Healthier at Home directive
Cooper made the comment at the media conference of the regular COVID-19 Task group.
"I expect news on the official expansion of the Healthier at house directive, perhaps tomorrow," Cooper said to press . "I believe people would expect, especially with either the news, that this will be prolonged for a duration of time till we are confident that somehow the outbreak rate in Nashville is decreasing."
Police announced on Sunday there have been 152 reported cases, bringing total reported cases for Nashville to 1,903, as per the Metro Population health Unit.
Cooper stated Monday would meet the current committee that was created amongst Nashville, Memphis, Knoxville and Chattanooga.
"This week that a lot of hard work is happening about how to make a reboot and I believe there would be a lot of change by the middle of week," Cooper stated.
The rise in cases reported in Davidson Community might delay a possibility of financially reopening the area.
"Again we're focusing about how to get a stable reboot. We're waiting for the transfer rate to go down so we can resume."
City Nashville Police Department is looking into shooting in the southern area of Nashville.
Police officers rushed to FA Napier Homes, Five-hundred block of Charles E. Davis, south of Nashville, following a man has been presumably shot at Five: Fifteen p.m. on Sat.
Metropolitan Nashville cops claim a target with a gunshot wrapped to the below limbs was discovered and transferred to Vanderbilt University Healthcare Facility with non-life harmful accidental injuries.
Cops are looking into the case and trying to find a defendant.
Other News United States Of America
President-elect Biden and Vice President-elect Harris are committed to making sure communities of color, our rural neighbors, those living with disabilities, and seniors are not left behind in our vaccination plans
Welcome to the Patriot party!
If you haven't already be sure to to sign up to become a member. We want to abandon the Republican party that turned their back on us. We will register as independents until the new party is formed. You can register at :
Visit the website for information and scroll the menu to register as a new member to be on our mailing list.
Thank you and welcome!
Val Ojeda, Chairman
Other world news
How SA’s nascent vaccine industry can be developed - Business Day
If SA is serious about supplying anti-pandemic vaccines in the future, it needs to rethink the scale of financial, technical and strategic investment into vaccine production
The issue of vaccine production has become a topic of hot debate following the approval of treatments for COVID-19. In SA, angry exchanges have been spurred by the countrys lagging access to Covid-19 vaccines. Generally, vaccines are produced by private companies that sell the vaccine under contracts. In some cases, producers will make provisions for access in particular markets. This is sometimes as a condition for receiving early development funding or for allowing parts of production to occur in a particular country. Some middle-income countries, particularly India, Argentina and Mexico, have sufficient production capacity to be partly indispensable. These countries have strategic leverage to get vaccines because of their own vaccine manufacturing capacity. India illustrates this well. The Serum Institute of India (SII), a privately owned pharmaceutical company, is manufacturing large quantities of the University of Oxford/AstraZeneca and Novavax vaccines. The company is scheduled to reach 100-million doses produced a month by March 2021. In return, India will keep a portion of the vaccines it manufactures reportedly 100-million doses in the first instance. What about SAs own capacity to produce vaccines? What can the country do? SA does not have large-scale vaccine manufacturing capability. The Biovac Institute a public-private partnership between the government and a consortium of SA health-care companies is beginning to get into vaccine manufacture with an eye on more secure and accessible childhood vaccine supplies for Southern Africa. But this capability is still in its infancy. Its small compared to the Covid-19 vaccine market. In addition, a publicly traded SA-owned global pharmaceutical company, Aspen Pharmaceuticals, operates four pharmaceutical manufacturing and packaging plants in the country. The company is also moving into the vaccine packaging market. We see a clear disconnect between what would be needed to make Biovac a strategic vaccine asset and what is planned for Biovac. If SA is serious about supplying anti-pandemic vaccines in the future, it needs to rethink the scale of financial, technical and strategic investment into vaccine production. This investment must be made not only into the private sector, but also, critically, into publicly accountable institutions such as Biovac. Only if investment is increased, sustained, and backed by political commitment, will the country have sufficient vaccine production capacity to use as a lever to get national and regional access to future anti-pandemic vaccines. Vaccine production capacity Biovacs primary remit is to make childhood vaccines available for the Southern African market, mostly for the public sector. For its part, Aspens existing pharmaceutical manufacturing capacity is about 10-billion tablets a year. It produces generic drugs (including analgesics, a proton pump inhibitor and sleeping aids), nutritional supplements (notably iron supplements) and hormones for local African markets and other middle income markets, such as Turkey. Aspen is scheduled to start producing the Johnson & Johnson Covid-19 vaccine in March or April at these facilities. It will be filling and packaging vials with vaccine product manufactured in bulk outside SA. Most of the vials will be shipped back to J &J for international distribution. A recent announcement indicates that 9-million doses will remain in SA for local use. The original packaging deal between Aspen and J&J was announced more than two months prior. There had been no mention of a procurement deal for SA until pressure began to mount recently on all parties. Unlike Aspen, Biovacs remit is to provide vaccines in the public interest. Part of its mission is, to provide in the long term, capacity for the development and introduction of novel vaccines, focusing on the development of vaccines relevant to SA and Africas particular needs. Biovacs main activity is to import, label and distribute vaccines to the SA market. For example, it has supplied six vaccines made by international vaccine manufacturers for SAs childhood immunisation programme. It also supplies other countries in the region. Biovacs crowning achievement has been the local production (filling and packaging) of Hexaxim, a combination of six childhood vaccines from Sanofi, the French multinational pharmaceutical company. Production started very recently, in November 2020. Biovac is the first external company with which Sanofi has partnered to fill and package Hexaxim. Biovac is also planning to manufacture Prevnar 13, a vaccine made by Pfizer, the US multinational pharmaceutical company. The vaccine prevents pneumococcal disease and death. Biovac will formulate the product using components provided by Pfizer before filling and packaging the bulk vaccine. Production is due to start in the next six months. The development of local capacity for formulation of a complex vaccine marks another important step towards the establishment of vaccine manufacturing capacity in SA.
McGregor knocked out by Poirier in stunning UFC upset - Eyewitness News
The 32-year-old Poirier was ranked second in the flyweight division going into the fight, but still rated a heavy underdog by bookmakers to beat his fourth-ranked opponent, arguably the most famous fighter the sport has seen.
The 32-year-old Poirier was ranked second in the flyweight division going into the fight, but still rated a heavy underdog by bookmakers to beat his fourth-ranked opponent, arguably the most famous fighter the sport has seen. ABU DHABI - American underdog Dustin Poirier shook up the world of mixed martial arts Sunday, beating up the legs of Irish superstar Conor McGregor before knocking him out at UFC 257 in Abu Dhabi. "I'm happy but I'm not surprised. I put in the work," Poirier after the referee stepped in after 2min 32sec of the second round to save McGregor from further damage after he was dropped by a fierce combination of punches. The 32-year-old Poirier was ranked second in the flyweight division going into the fight, but still rated a heavy underdog by bookmakers to beat his fourth-ranked opponent, arguably the most famous fighter the sport has seen. The controversial McGregor, known as "Notorious", was returning to the octagon for the first time in a year and hoping for a repeat of the pair's first contest in 2014 which he won by TKO after just 109 seconds. But Poirier, who now has a UFC record of 27-6, used low calf kicks in an effort to put McGregor (22-5) off his usual ferocious stand-up game - and it worked. "First off I want to say Conor took this result professionally. We're 1-1 and maybe we're going to have to do it again," said Poirier, hinting at the prospect of a trilogy fight. "I'm happy with the place I am in. I'm happy with the face I see in the mirror. "The goal was to be technical and to pick my shots, not brawl at all. I had him hurt and I went a little crazy." McGregor likes to call himself "Mystic Mac" and had spent the week leading into the fight predicting he would end it inside 60 seconds. But it was a different Poirier to the one who had looked overmatched when the pair previously met at UFC 178 at the lighter featherweight. 'I'M GUTTED' Poirier worked the legs and took McGregor down into a grapple for much of the first round -- avoiding a boxing face-off against a man who once shared the ring with Floyd Mayweather and had touted a future fight against Manny Pacquiao. Poirier then found his range in the second, weakening McGregor's base with more calf kicks before exploding for the shock finish. He staggered McGregor with a big overhand left and then dropped him to the canvas with a straight right flush on the Irishman's nose before referee Herb Dean waved it off. "The low calf kick was very good but Dustin is some fighter," said McGregor. "I'll dust it off and come back because that's what I'll do. I'll take my licks. "I'm gutted, it's a tough one to swallow. I just want to go back to the hotel and chill with my kids and regroup." The second-ranked Poirier is now in prime position to either inherit or fight for the UFC's lightweight belt, most recently held by the now-retired unbeaten Russian Khabib Nurmagomedov. "I felt like this was the title fight. If Khabib's not coming back then I'm the champion," said Poirier. The fight was held inside the new Etihad Arena on the "Fight Island" bio-secure sporting hub of Yas Island that the Abu Dhabi government established last July. The three UFC events staged over the past week have been the first to allow fans to sit cageside, with around 2,000 in attendance for the main event. Download the Eyewitness News app to your iOS or Android device.
Liverpool will face different Manchester United, and may have to suffer at centre-back - Liverpool.com
Wake Up with Liverpool.com: The Reds head to Old Trafford with a potentially new defensive partnership, and are set to come up against a very different United approach.
Liverpool head to Old Trafford today in search of a morale boosting victory which can hopefully reinvigorate their slumping league form. To do so, they will have to come up against a Manchester United side which will have a very different gameplan than the one at Anfield a couple of weeks back, and they could be helped by the visitors own team selection. In our pre-match video, I predict Liverpool may go with the untested centre-back partnership of Nat Phillips and Rhys Williams given how much football Fabinho has played and the fragile nature of the returning Joel Matip. In doing so, Liverpool could well come up against a front-three of Edinson Cavani, Marcus Rashford and Mason Greenwood, which would invariably present problems for the champions. I was really relieved when Greenwood wasn't given too much time at Anfield. As I state on the video, I really like him and think his finishing and prowess in front of goal is quietly excellent. It could be a tough afternoon for Liverpool, this, and ultimately they may have to suffer a little longer than anyone wants right now before we see the other side of this form. The next three of United, Tottenham and West Ham could have been kinder, and they will certainly test Liverpool's willingness to fight. One thing is for sure, Liverpool will face a team today who wants to attack and play football against them. That alone should guarantee goals, who scores them is another question entirely. What I'm reading on Liverpool.com Joel has made an excellent point on the general argument around centre-backs at Liverpool. He explores rightly whether what is going on is now way beyond problems from the back, despite the argument of losing players from other positions and build up play. Also, should Liverpool still have their 2020 Premier League parade when the time is right? I pondered that argument here. What I'm listening to Me, on the Radio playing music and very much not talking about football. I return to Svara Radio today for my first PMCD show of the year. You can listen as I take you through some ambient sounds for your Sunday from 12pm GMT